SLEEP NUMBER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.18 USD | -0.35% |
|
+4.19% | -4.38% |
| 04-25 | UBS Adjusts Sleep Number Price Target to $13 From $12, Maintains Neutral Rating | MT |
| 04-25 | Piper Sandler Adjusts Price Target on Sleep Number to $13 From $12, Keeps Neutral Rating | MT |
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.14 for the 2024 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Home Furnishings
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -4.38% | 317M | C | ||
| -2.06% | 8.67B | B | ||
| -4.20% | 3.79B | C- | ||
| +5.08% | 2.22B | C | ||
| +6.69% | 1.8B | - | ||
| -10.32% | 1.41B | B- | ||
| -27.03% | 1.18B | C+ | ||
| +28.08% | 1.13B | - | ||
| +4.35% | 928M | - | ||
| -2.98% | 816M | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SNBR Stock
- Ratings Sleep Number Corporation
